encouraging results for immutep's cancer therapies
Published 7 months ago • 33 plays • Length 10:01Download video MP4
Download video MP3
Similar videos
-
8:42
immutep (asx:imm) announces positive results in head and neck cancer treatment
-
47:53
immutep (asx:imm) tacti-003 results, june 2024
-
12:28
clinical trials in cancer and autoimmune diseases: immutep's ceo marc voigt provides an update
-
16:06
immutep (asx:imm) - webinar presentation
-
4:40
immutep (asx:imm, nasdaq:immp) announces encouraging trial data for lung cancer therapy
-
50:22
immutep (asx:imm) esmo congress results webinar, october 2023
-
15:49
immutep (asx:imm) - webinar presentation
-
1:14:06
immutep webinar - sitc 2021 results - 17 november 2021
-
46:43
immutep (asx:bla) - tacti-003 positive data in patients with negative pd-l1 expression (cohort b)
-
1:14:06
immutep (asx:imm) sitc 2021 results - management update
-
16:07
immutep (asx:imm) - webinar presentation
-
7:58
immutep: a leader in a league alongside global pharma giants
-
6:25
immutep (asx:imm, nasdaq:immp) discusses a transformative year for lag-3 therapies
-
2:56
perioperative immunotherapy and surgery for treating msi-high esophagogastric tumors
-
4:44
immutep (asx:imm, nasdaq:immp) - innovative cancer therapies
-
2:23
immunotherapy 2.0: smarter use, better results
-
0:58
immunotherapy | stand up to cancer
-
3:24
replacing autosct with immunotherapies: pros and cons